1. Home
  2. RCUS vs WINA Comparison

RCUS vs WINA Comparison

Compare RCUS & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • WINA
  • Stock Information
  • Founded
  • RCUS 2015
  • WINA 1988
  • Country
  • RCUS United States
  • WINA United States
  • Employees
  • RCUS N/A
  • WINA N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • WINA Other Specialty Stores
  • Sector
  • RCUS Health Care
  • WINA Consumer Discretionary
  • Exchange
  • RCUS Nasdaq
  • WINA Nasdaq
  • Market Cap
  • RCUS 1.4B
  • WINA 1.4B
  • IPO Year
  • RCUS 2018
  • WINA 1993
  • Fundamental
  • Price
  • RCUS $14.15
  • WINA $396.66
  • Analyst Decision
  • RCUS Buy
  • WINA Strong Buy
  • Analyst Count
  • RCUS 12
  • WINA 1
  • Target Price
  • RCUS $34.50
  • WINA $445.00
  • AVG Volume (30 Days)
  • RCUS 583.4K
  • WINA 18.7K
  • Earning Date
  • RCUS 02-19-2025
  • WINA 02-19-2025
  • Dividend Yield
  • RCUS N/A
  • WINA 0.66%
  • EPS Growth
  • RCUS N/A
  • WINA N/A
  • EPS
  • RCUS N/A
  • WINA 10.93
  • Revenue
  • RCUS $263,000,000.00
  • WINA $81,781,000.00
  • Revenue This Year
  • RCUS $127.65
  • WINA $0.47
  • Revenue Next Year
  • RCUS N/A
  • WINA $4.86
  • P/E Ratio
  • RCUS N/A
  • WINA $35.90
  • Revenue Growth
  • RCUS 119.17
  • WINA N/A
  • 52 Week Low
  • RCUS $13.51
  • WINA $330.25
  • 52 Week High
  • RCUS $20.31
  • WINA $431.67
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 39.00
  • WINA 53.05
  • Support Level
  • RCUS $13.81
  • WINA $365.83
  • Resistance Level
  • RCUS $14.45
  • WINA $391.04
  • Average True Range (ATR)
  • RCUS 0.57
  • WINA 7.08
  • MACD
  • RCUS -0.06
  • WINA 0.85
  • Stochastic Oscillator
  • RCUS 30.40
  • WINA 95.10

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

Share on Social Networks: